stocks logo

SCNI

Scinai Immunotherapeutics Ltd
$
2.060
-0.08(-3.738%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
2.150
Open
2.130
VWAP
2.09
Vol
39.90K
Mkt Cap
1.76M
Low
2.050
Amount
83.54K
EV/EBITDA(TTM)
--
Total Shares
581.14K
EV
5.68M
EV/OCF(TTM)
--
P/S(TTM)
2.18
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Show More

Valuation Metrics

The current forward P/E ratio for Scinai Immunotherapeutics Ltd (SCNI.O) is 0.00, compared to its 5-year average forward P/E of -349.18. For a more detailed relative valuation and DCF analysis to assess Scinai Immunotherapeutics Ltd 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-349.18
Current PE
0.00
Overvalued PE
1048.87
Undervalued PE
-1747.22

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

Annual
Quarterly
FY2024Q4
206.00K
Total Revenue
FY2024Q4
YoY :
+25.62%
-2.29M
Operating Profit
FY2024Q4
YoY :
-4.29%
-2.23M
Net Income after Tax
FY2024Q4
YoY :
-100.00%
0.00
EPS - Diluted
FY2024Q4
YoY :
-26.25%
-1.08M
Free Cash Flow
FY2024Q4
-81.07
Gross Profit Margin - %
FY2024Q4
-964.59
FCF Margin - %
FY2024Q4
-1.08K
Net Margin - %

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

SCNI News & Events

Events Timeline

2025-03-05 (ET)
2025-03-05
07:31:58
Scinai Immunotherapeutics announces $10M standby equity purchase agreement
select
2025-03-04 (ET)
2025-03-04
17:28:27
Scinai Immunotherapeutics files to sell 3.02M ADS for holders
select
2024-08-29 (ET)
2024-08-29
06:35:55
Scinai Immunotherapeutics regains compliance with Nasdaq
select
Sign Up For More Events

News

7.5
06-26PRnewswire
Scinai Highlights Award-Winning Science Behind PC111 as Key Pincell Researcher Receives "Oscar of Italian Dermatology"
8.5
06-12PRnewswire
Scinai Highlights New Funding and CDMO Growth Ahead of BIO International Convention 2025
8.5
06-05Newsfilter
Scinai Immunotherapeutics Receives Italian Government Clearance Under Golden Power Regulation for Potential Acquisition of Pincell S.r.l.
Sign Up For More News

FAQ

arrow icon

What is Scinai Immunotherapeutics Ltd (SCNI) stock price today?

The current price of SCNI is 2.06 USD — it has decreased -3.74 % in the last trading day.

arrow icon

What is Scinai Immunotherapeutics Ltd (SCNI)'s business?

arrow icon

What is the price predicton of SCNI Stock?

arrow icon

What is Scinai Immunotherapeutics Ltd (SCNI)'s revenue for the last quarter?

arrow icon

What is Scinai Immunotherapeutics Ltd (SCNI)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Scinai Immunotherapeutics Ltd (SCNI)'s fundamentals?

arrow icon

How many employees does Scinai Immunotherapeutics Ltd (SCNI). have?

arrow icon

What is Scinai Immunotherapeutics Ltd (SCNI) market cap?